Dataset from Randomized Pragmatic Clinical Trial in a Community-Based Setting Comparing STIOLTO® RESPIMAT® vs. ICS-LABA Plus LAMA in Patients With COPD
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007877
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of this pragmatic study is to compare the time to first moderate or
severe COPD exacerbation in patients, not controlled on their current therapy, randomized to
Stiolto Respimat versus triple therapy over 12 months of treatment
The secondary objectives of this study include:
1. To compare the annual rate of moderate or severe COPD exacerbations for patients on
Stiolto Respimat with patients on triple therapy.
2. To compare the time to first severe COPD exacerbation in both treatment arms.
3. To compare the annual rate of severe COPD exacerbations in both treatment arms.
4. To compare the proportion of patients with moderate or severe COPD exacerbations in both
treatment arms.
创建时间：
2024-11-26
